trinitrobenzenesulfonic acid has been researched along with Disease Exacerbation in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fricker, M; Gellatly, SL; Goggins, BJ; Hansbro, PM; Jarnicki, AG; Jones, B; Keely, S; Kim, RY; Mateer, S; Oliver, BG; Powell, N; Radford-Smith, G; Talley, NJ; Walker, MM | 1 |
| Alexander, JS; Cromer, WE; Ganta, CV; Kevil, CG; Mathis, JM; Patel, M; Traylor, J | 1 |
| Che, X; Fan, HY; Liu, K; Lv, WH; Song, WW; Xu, H; Yang, MY; Zhang, ZL | 1 |
| Devisscher, L; Filtjens, J; Kerre, T; Leclercq, G; Plum, J; Taghon, T; Taveirne, S; Van Acker, A; Van Ammel, E; Van Welden, S; Vandekerckhove, B; Vanhees, M | 1 |
| Jian, J; Lafaille, JJ; Lin, J; Liu, CJ; Mundra, JJ; Tang, W; Tian, Q; Wei, F; Yu, X; Zhang, Y; Zhao, W | 1 |
| Ávila-Román, J; García-Mauriño, S; Motilva, V; Rodríguez-Luna, A; Talero, E | 1 |
| Basta, F; Bhatia, M; Bovi, G; de Joannon, AC; Guglielmotti, A; Landolfi, C; Ramnath, RD | 1 |
| Alex, P; Centola, M; Chen, TE; Conklin, LS; Gonzales, L; Li, X; Nguyen, T; Zachos, NC | 1 |
| Hobson, AR; James, MF; Kruidenier, L; Lewis, HD; McCleary, S; Pohlmann, A; Robinson, A; Tilling, LC; Warnock, LC; Woolmer, O | 1 |
| Ebersole, JL; Oz, HS | 1 |
| Appleyard, CB; Chen, Z; Coppola, D; Isidro, AA; Pagán, B; Ren, Y; Wu, J | 1 |
| Fakhrejahani, E; Kawaguchi-Sakita, N; Liao, Y; Qian, N; Raut, V; Tang, Y; Toi, M | 1 |
| Adams, MR; Bhargava, A; Brooks, JH; Chang, J; Clifton, MS; Hasdemir, B; Liao, M | 1 |
| Higgins, PD; Johnson, LA; Kim, K; McKenna, BJ; Moons, DS; Rubin, JM; Stidham, RW; Xu, J | 1 |
| Appleyard, CB; Coppola, D; Cruz, ML; Isidro, AA; Pagán, B; Ren, Y; Wu, J | 1 |
| de Villiers, WJ; Oz, HS; Zhong, J | 1 |
| Goldin, E; Israeli, E; Latella, G; Lysy, J; Metanes, I; Necozione, S; Papo, O; Pines, M; Wengrower, D; Zanninelli, G | 1 |
| Andoh, A; Araki, Y; Fujiyama, Y; Ishizuka, I; Koyama, S; Sasaki, M; Tsujikawa, T | 1 |
| Galle, PR; Goetz, M; Lehr, HA; Neurath, MF; Orth, T | 1 |
| Colgan, SP; Karhausen, J; Louis, NA; MacManus, CF; Robinson, AM; Scully, M | 1 |
| Dayan, D; Eyal, A; Rabau, M | 1 |
| Ajuebor, MN; Hogaboam, CM; Kunkel, SL; Proudfoot, AE; Wallace, JL | 1 |
| Boirivant, M; De Pascale, M; Ferroni, L; Fuss, IJ; Strober, W | 1 |
| Chin, JE; Krzesicki, RF; Lai, PS; Nagele, RG; Sun, FF; Tong, DM; Wong, PY; Yin, K; Yue, G | 1 |
24 other study(ies) available for trinitrobenzenesulfonic acid and Disease Exacerbation
| Article | Year |
|---|---|
Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.
Topics: Adult; Aged; Amino Acids, Dicarboxylic; Animals; Biopsy; Cell Hypoxia; Colon; Colonoscopy; Crohn Disease; Disease Models, Animal; Disease Progression; Female; Humans; Ileum; Intestinal Mucosa; Lung; Male; Mice; Mice, Inbred C57BL; Middle Aged; Nicotiana; Oxidative Stress; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Risk Factors; Smoke; Smoking; Smoking Cessation; Time Factors; Trinitrobenzenesulfonic Acid | 2018 |
VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.
Topics: Animals; Blood Vessels; Cell Aggregation; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Disease Progression; HEK293 Cells; Humans; Leukocytes; Lymphatic Vessels; Mice; Organ Size; Protective Agents; Protein Isoforms; Trinitrobenzenesulfonic Acid; Vascular Endothelial Growth Factor A | 2013 |
Effectiveness of a hydroxynaphthoquinone fraction from Arnebia euchroma in rats with experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Boraginaceae; Colitis, Ulcerative; Colon; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Gastrointestinal Agents; Goblet Cells; Inflammation Mediators; Male; Mesalamine; Naphthoquinones; Peroxidase; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |
Ly49E expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseases.
Topics: Animals; CD8 Antigens; Cell Count; Colitis; Colon; Dextran Sulfate; Disease Progression; Epithelial Cells; Ileitis; Inflammatory Bowel Diseases; Intestines; Lymphocytes; Mice, Inbred C57BL; Mice, Knockout; NK Cell Lectin-Like Receptor Subfamily A; Receptors, Natural Killer Cell; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2014 |
PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; CD4-Positive T-Lymphocytes; Dextran Sulfate; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Granulins; Humans; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Interleukin-10; Mice; Mice, Knockout; Progranulins; Receptors, Tumor Necrosis Factor, Type II; Recombinant Proteins; Signal Transduction; Transplantation Chimera; Trinitrobenzenesulfonic Acid | 2014 |
Anti-inflammatory effects of an oxylipin-containing lyophilised biomass from a microalga in a murine recurrent colitis model.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomass; Chlamydomonas; Colitis, Ulcerative; Colon; Cytokines; Dietary Supplements; Disease Models, Animal; Disease Progression; Female; Freeze Drying; Gene Expression Regulation; Intestinal Mucosa; Mice, Inbred BALB C; Microalgae; Neutrophil Infiltration; Oxidative Stress; Oxylipins; Secondary Prevention; Trinitrobenzenesulfonic Acid | 2016 |
Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Cells, Cultured; Chemokine CCL2; Colitis; Disease Progression; Epithelial Cells; Female; Humans; Indazoles; Interferon-gamma; Mice; Mice, Inbred BALB C; Propionates; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |
Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.
Topics: Animals; Blotting, Western; Chronic Disease; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Disease Progression; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peroxidase; Trinitrobenzenesulfonic Acid | 2009 |
Progression and variability of TNBS colitis-associated inflammation in rats assessed by contrast-enhanced and T2-weighted MRI.
Topics: Anesthetics, Inhalation; Animals; Colitis; Colon; Contrast Media; Disease Models, Animal; Disease Progression; Gastrointestinal Agents; Isoflurane; Magnetic Resonance Imaging; Male; Organ Size; Rats; Rats, Wistar; Severity of Illness Index; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2009 |
A novel murine model for chronic inflammatory alveolar bone loss.
Topics: Administration, Oral; Alveolar Bone Loss; Alveolar Process; Animals; Chronic Periodontitis; Colon; Cystine; Dextran Sulfate; Disease Models, Animal; Disease Progression; Liver; Mandibular Diseases; Maxillary Diseases; Mice; Mice, Inbred BALB C; Mice, SCID; Periodontium; Time Factors; Trinitrobenzenesulfonic Acid | 2010 |
Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Transformation, Neoplastic; Colitis; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Immunohistochemistry; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2010 |
Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats.
Topics: Actins; Animals; Biomarkers; Blotting, Western; Cyclooxygenase 2; Disease Models, Animal; Disease Progression; Drugs, Chinese Herbal; Interleukin-10; Interleukin-1beta; Pancreas; Pancreatitis, Chronic; Rats; Rats, Sprague-Dawley; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.
Topics: Animals; Blotting, Western; Colitis; Disease Progression; Edema; Extracellular Signal-Regulated MAP Kinases; Immunohistochemistry; Kinetics; Male; Peroxidase; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Signal Transduction; Trinitrobenzenesulfonic Acid; Urocortins | 2011 |
Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease.
Topics: Animals; Biomechanical Phenomena; Colitis; Colon; Crohn Disease; Diagnosis, Differential; Diagnostic Imaging; Disease Models, Animal; Disease Progression; Elasticity; Female; Fibrosis; Humans; Inflammation; Inflammatory Bowel Diseases; Intestine, Small; Pilot Projects; Rats; Rats, Inbred Lew; Trinitrobenzenesulfonic Acid; Ultrasonography | 2011 |
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.
Topics: Animals; Cell Line; Cell Proliferation; Colitis; Colon; Colonic Neoplasms; Disease Models, Animal; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Humans; Male; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2011 |
Osteopontin ablation attenuates progression of colitis in TNBS model.
Topics: Animals; Biopsy, Needle; Colitis; Disease Models, Animal; Disease Progression; Flow Cytometry; Immunohistochemistry; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; Random Allocation; Reference Values; Sensitivity and Specificity; Serum Amyloid A Protein; Trinitrobenzenesulfonic Acid | 2012 |
Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Colitis; Disease Models, Animal; Disease Progression; Down-Regulation; Fibrosis; Intestinal Mucosa; Losartan; Male; Rats; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid | 2012 |
N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis.
Topics: alpha-Linolenic Acid; Animal Feed; Animals; Diet; Disease Progression; Enteritis; Inflammatory Bowel Diseases; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2003 |
Long-term evaluation of a rat model of chronic cholangitis resembling human primary sclerosing cholangitis.
Topics: Alanine Transaminase; Animals; Antibodies, Antineutrophil Cytoplasmic; C-Reactive Protein; Cholangitis, Sclerosing; Chronic Disease; Disease Models, Animal; Disease Progression; Female; Humans; Liver; Rats; Rats, Inbred Lew; Trinitrobenzenesulfonic Acid | 2003 |
Control of IFN-alphaA by CD73: implications for mucosal inflammation.
Topics: 5'-Nucleotidase; Acute Disease; Adenosine Diphosphate; Animals; Colitis; Disease Progression; Down-Regulation; Inflammation Mediators; Interferon-alpha; Interleukin-10; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; RNA, Messenger; Trinitrobenzenesulfonic Acid | 2008 |
Histomorphometric evaluation of experimentally induced colitis with trinitrobenzene-sulphonic acid in rats.
Topics: Acute Disease; Animals; Colitis; Colon; Disease Progression; Fibrosis; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Necrosis; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid | 1996 |
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.
Topics: Acute Disease; Administration, Rectal; Animals; Cell Movement; Chemokine CCL5; Chronic Disease; Colitis; Disease Progression; Dose-Response Relationship, Drug; Haptens; Inflammation Mediators; Injections, Intravenous; Leukocyte Count; Male; Mast Cells; Monocytes; Rats; Rats, Wistar; Receptors, CCR1; Receptors, CCR5; Receptors, Chemokine; RNA, Messenger; Time Factors; Trinitrobenzenesulfonic Acid | 2001 |
Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis.
Topics: Administration, Oral; Administration, Rectal; Animals; Apoptosis; Cells, Cultured; Cholera Toxin; Colitis; Colon; Disease Progression; Interferon-gamma; Interleukin-10; Interleukin-12; Interleukin-4; Intestinal Mucosa; Leukocytes, Mononuclear; Male; Mice; Mice, Inbred Strains; Oxazolone; Recombinant Proteins; Transforming Growth Factor beta; Trinitrobenzenesulfonic Acid | 2001 |
Pattern of cytokine and adhesion molecule mRNA in hapten-induced relapsing colon inflammation in the rat.
Topics: Animals; Cell Adhesion Molecules; Chronic Disease; Colitis; Cytokines; Disease Models, Animal; Disease Progression; E-Selectin; Gene Expression Regulation; Granulocytes; Haptens; Inflammatory Bowel Diseases; Integrin beta Chains; Integrins; Intercellular Adhesion Molecule-1; Interferon-gamma; Intestinal Mucosa; Monocytes; P-Selectin; Rats; Rats, Sprague-Dawley; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Trinitrobenzenesulfonic Acid; Vascular Cell Adhesion Molecule-1 | 2001 |